Inactive Instrument

Gentian Diagnostics AS Stock price Oslo Bors

Equities

NO0010748866

Medical Equipment, Supplies & Distribution

Sales 2024 * 171M 15.72M Sales 2025 * 203M 18.71M Capitalization 598M 55.18M
Net income 2024 * -11M -1.01M Net income 2025 * -6M -553K EV / Sales 2024 * 3.31 x
Net cash position 2024 * 34M 3.14M Net cash position 2025 * 15M 1.38M EV / Sales 2025 * 2.88 x
P/E ratio 2024 *
-51.9 x
P/E ratio 2025 *
-91.1 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 54.81%
More Fundamentals * Assessed data
Dynamic Chart
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair MT
Gentian Diagnostics ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Transcript : Gentian Diagnostics ASA, Q4 2023 Earnings Call, Feb 09, 2024
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors CI
Gentian Diagnostics ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Gentian Diagnostics ASA, Q3 2023 Earnings Call, Oct 26, 2023
Gentian Diagnostics ASA Expands Product Portfolio With Turbidimetric Retinol-Binding Protein Immunoassay CI
Gentian Diagnostics ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Gentian Diagnostics ASA, Q2 2023 Earnings Call, Aug 24, 2023
Gentian Diagnostics ASA (OB:GENT) acquired Getica Ab from Erling Sundrehagen for SEK 2.8 million. CI
Norway's Gentian Diagnostics Buys Sweden-based Getica in SEK3 Million Deal MT
Gentian Diagnostics ASA (OB:GENT) entered into an agreement to acquire Getica Ab from Erling Sundrehagen for SEK 3 million. CI
Transcript : Gentian Diagnostics ASA - Analyst/Investor Day
Transcript : Gentian Diagnostics ASA, Q1 2023 Earnings Call, May 05, 2023
Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer - 18-07-15
Director of Finance/CFO 52 18-01-01
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 64 -
Director/Board Member 44 -
Director/Board Member 60 -
More insiders
Gentian Diagnostics ASA is a Norway-based company within health care sector. The Company develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company's product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The Company is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Gentian Diagnostics
  4. Stock Gentian Diagnostics AS - Oslo Bors